{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:54:34Z","timestamp":1793073274551,"version":"4.5.0"},"reference-count":95,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Card Fail Rev"],"abstract":"<jats:p>Obstructive sleep apnoea and central sleep apnoea are common disorders, particularly in people with congestive heart failure. Continuous positive airway pressure provides transformative benefits for some patients, but is not always well tolerated. Thus, considerable focus is now being placed on alternative therapies for sleep-disordered breathing, including non-positive airway pressure therapy. Advances in pharmacology have led to a variety of options to treat both obstructive and central sleep apnoea. In addition, these approaches may have major benefits from the perspective of preventing the complications of sleep-disordered breathing. In the case of tirzepatide, the Food and Drug Administration recently approved this medication for the treatment of moderate-to-severe sleep apnoea in people with obesity. However, further data are required regarding how best to improve both subjective and objective hard outcomes in people with congestive heart failure and sleep-disordered breathing.<\/jats:p>","DOI":"10.15420\/cfr.2025.24","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:38:59Z","timestamp":1788946739000},"source":"Crossref","is-referenced-by-count":1,"title":["Non-positive Airway Pressure Therapies for Obstructive Sleep Apnoea and Central Sleep Apnoea"],"prefix":"10.15420","author":[{"given":"Jorge","family":"Mora","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00b30xv10","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8616-1053","authenticated-orcid":false,"given":"Bernie","family":"Sunwoo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0168r3w48","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus","family":"Ramsis","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0168r3w48","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9509-1827","authenticated-orcid":false,"given":"Atul","family":"Malhotra","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0168r3w48","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med 2019;7:687\u201398. https:\/\/doi.org\/10.1016\/S2213-2600(19)30198-5; PMID: 31300334. DOI: 10.1016\/S2213-2600(19)30198-5","DOI":"10.1016\/S2213-2600(19)30198-5"},{"key":"ref1","unstructured":"Javaheri S. Central sleep apnea-hypopnea syndrome in heart failure: prevalence, impact, and treatment. Sleep 1996;19(10)(Suppl):S229\u201331. PMID: 9085518."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Sin DD, Fitzgerald F, Parker JD, et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999;160:1101\u20136. https:\/\/doi.org\/10.1164\/ajrccm.160.4.9903020; PMID: 10508793. DOI: 10.1164\/ajrccm.160.4.9903020","DOI":"10.1164\/ajrccm.160.4.9903020"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Jenkinson C, Davies RJ, Mullins R, Stradling JR. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999;353:2100\u20135. https:\/\/doi.org\/10.1016\/S0140-6736(98)10532-9; PMID: 10382693. DOI: 10.1016\/S0140-6736(98)10532-9","DOI":"10.1016\/S0140-6736(98)10532-9"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Pepperell JCT, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002;359:204\u201310. https:\/\/doi.org\/10.1016\/S0140-6736(02)07445-7; PMID: 11812555. DOI: 10.1016\/S0140-6736(02)07445-7","DOI":"10.1016\/S0140-6736(02)07445-7"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Patel SR, White DP, Malhotra A, et al. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med 2003;163:565\u201371. https:\/\/doi.org\/10.1001\/archinte.163.5.565; PMID: 12622603. DOI: 10.1001\/archinte.163.5.565","DOI":"10.1001\/archinte.163.5.565"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Weaver TE, Mancini C, Maislin G, et al. Continuous positive airway pressure treatment of sleepy patients with milder obstructive sleep apnea: results of the CPAP Apnea Trial North American Program (CATNAP) randomized clinical trial. Am J Respir Crit Care Med 2012;186:677\u201383. https:\/\/doi.org\/10.1164\/rccm.201202-0200OC; PMID: 22837377. DOI: 10.1164\/rccm.201202-0200OC","DOI":"10.1164\/rccm.201202-0200OC"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Benjafield A, Pepin JL, Cistulli PA, et al. Positive airway pressure therapy and all-cause and cardiovascular mortality in people with obstructive sleep apnoea: a systematic review and meta-analysis of randomized clinical trials and confounder-adjusted, non-randomised controlled studies. Lancet Respir Med 2025;13:403\u201313. https:\/\/doi.org\/10.1016\/s2213-2600(25)00002-5; PMID: 40118084. DOI: 10.1016\/S2213-2600(25)00002-5","DOI":"10.1016\/S2213-2600(25)00002-5"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003;348:1233\u201341. https:\/\/doi.org\/10.1056\/NEJMoa022479; PMID: 12660387. DOI: 10.1056\/NEJMoa022479","DOI":"10.1056\/NEJMoa022479"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Naughton MT, Benard DC, Liu PP, et al. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1995;152:473\u20139. https:\/\/doi.org\/10.1164\/ajrccm.152.2.7633695; PMID: 7633695. DOI: 10.1164\/ajrccm.152.2.7633695","DOI":"10.1164\/ajrccm.152.2.7633695"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Malhotra A, Crocker ME, Willes L, et al. Patient engagement using new technology to improve adherence to positive airway pressure therapy: a retrospective analysis. Chest 2018;153:843\u201350. https:\/\/doi.org\/10.1016\/j.chest.2017.11.005; PMID: 29154970. DOI: 10.1016\/j.chest.2017.11.005","DOI":"10.1016\/j.chest.2017.11.005"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Cistulli PA, Armitstead J, Pepin JL, et al. Short-term CPAP adherence in obstructive sleep apnea: a big data analysis using real world data. Sleep Med 2019;59:114\u20136. https:\/\/doi.org\/10.1016\/j.sleep.2019.01.004; PMID: 30799254. DOI: 10.1016\/j.sleep.2019.01.004","DOI":"10.1016\/j.sleep.2019.01.004"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Bradley TD, Logan AG, Lorenzi Filho G, et al. Adaptive servo-ventilation for sleep-disordered breathing in patients with heart failure with reduced ejection fraction (ADVENT-HF): a multicentre, multinational, parallel-group, open-label, phase 3 randomised controlled trial. Lancet Respir Med 2024;12:153\u201366. https:\/\/doi.org\/10.1016\/S2213-2600(23)00374-0; PMID: 38142697. DOI: 10.1016\/S2213-2600(23)00374-0","DOI":"10.1016\/S2213-2600(23)00374-0"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Patel SR, Sykes AV, Malhotra A. Sleep apnoea in congestive heart failure: one step forwards. Lancet Respir Med 2024;12:94\u20136. https:\/\/doi.org\/10.1016\/S2213-2600(23)00377-6; PMID: 38142696. DOI: 10.1016\/S2213-2600(23)00377-6","DOI":"10.1016\/S2213-2600(23)00377-6"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Cowie MR, Woehrle H, Wegscheider K, et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. N Engl J Med 2015;373:1095\u2013105. https:\/\/doi.org\/10.1056\/NEJMoa1506459; PMID: 26323938. DOI: 10.1056\/NEJMoa1506459","DOI":"10.1056\/NEJMoa1506459"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Cowie MR, Woehrle H, Wegscheider K, et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. Eur J Heart Fail 2018;20:536\u201344. https:\/\/doi.org\/10.1002\/ejhf.1048; PMID: 29193576. DOI: 10.1002\/ejhf.1048","DOI":"10.1002\/ejhf.1048"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet 2014;383:736\u201347. https:\/\/doi.org\/10.1016\/S0140-6736(13)60734-5; PMID: 23910433. DOI: 10.1016\/S0140-6736(13)60734-5","DOI":"10.1016\/S0140-6736(13)60734-5"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Floras JS, Bradley TD. Sleep apnoea in acute heart failure: fluid in flux. Eur Heart J 2015;36:1428\u201330. https:\/\/doi.org\/10.1093\/eurheartj\/ehv084; PMID: 25802394. DOI: 10.1093\/eurheartj\/ehv084","DOI":"10.1093\/eurheartj\/ehv084"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Yumino D, Redolfi S, Ruttanaumpawan P, et al. Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 2010;121:1598\u2013605. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.902452; PMID: 20351237. DOI: 10.1161\/CIRCULATIONAHA.109.902452","DOI":"10.1161\/CIRCULATIONAHA.109.902452"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Bucca CB, Brussino L, Battisti A, et al. Diuretics in obstructive sleep apnea with diastolic heart failure. Chest 2007;132:440\u20136. https:\/\/doi.org\/10.1378\/chest.07-0311; PMID: 17699130. DOI: 10.1378\/chest.07-0311","DOI":"10.1378\/chest.07-0311"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Somers VK, Anderson EA, Mark AL. Sympathetic neural mechanisms in human hypertension. Curr Opin Nephrol Hypertens 1993;2:96\u2013105. https:\/\/doi.org\/10.1097\/00041552-199301000-00015; PMID: 7922174. DOI: 10.1097\/00041552-199301000-00015","DOI":"10.1097\/00041552-199301000-00015"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995;96:1897\u2013904. https:\/\/doi.org\/10.1172\/JCI118235; PMID: 7560081. DOI: 10.1172\/JCI118235","DOI":"10.1172\/JCI118235"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 1993;328:303\u20137. https:\/\/doi.org\/10.1056\/NEJM199302043280502; PMID: 8419815. DOI: 10.1056\/NEJM199302043280502","DOI":"10.1056\/NEJM199302043280502"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Javaheri S, Barbe F, Campos-Rodriguez F, et al. Sleep apnea: types, mechanisms, and clinical cardiovascular consequences. J Am Coll Cardiol 2017;69:841\u201358. https:\/\/doi.org\/10.1016\/j.jacc.2016.11.069; PMID: 28209226. DOI: 10.1016\/j.jacc.2016.11.069","DOI":"10.1016\/j.jacc.2016.11.069"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Bradley TD, Floras JS. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 2009;373:82\u201393. https:\/\/doi.org\/10.1016\/S0140-6736(08)61622-0; PMID: 19101028. DOI: 10.1016\/S0140-6736(08)61622-0","DOI":"10.1016\/S0140-6736(08)61622-0"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Bradley TD, Logan AG, Kimoff RJ, et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005;353:2025\u201333. https:\/\/doi.org\/10.1056\/NEJMoa051001; PMID: 16282177. DOI: 10.1056\/NEJMoa051001","DOI":"10.1056\/NEJMoa051001"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Cistulli PA, Gotsopoulos H. Single-night titration of oral appliance therapy for obstructive sleep apnea: a step forward? Am J Respir Crit Care Med 2004;170:353\u20134. https:\/\/doi.org\/10.1164\/rccm.2405012; PMID: 15302623. DOI: 10.1164\/rccm.2405012","DOI":"10.1164\/rccm.2405012"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Ferguson KA, Ono T, Lowe AA, et al. A randomized crossover study of an oral appliance vs nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest 1996;109:1269\u201375. https:\/\/doi.org\/10.1378\/chest.109.5.1269; PMID: 8625679. DOI: 10.1378\/chest.109.5.1269","DOI":"10.1378\/chest.109.5.1269"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Fleetham JA, Ferguson KA, Lowe AA, Ryan CF. Oral appliance therapy for the treatment of obstructive sleep apnea. Sleep 1996;19(10)(Suppl):S288\u201390. https:\/\/doi.org\/10.1093\/sleep\/19.suppl_10.S288; PMID: 9085534. DOI: 10.1093\/sleep\/19.suppl_10.S288","DOI":"10.1093\/sleep\/19.suppl_10.S288"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Almeida FR, Henrich N, Marra C, et al. Patient preferences and experiences of CPAP and oral appliances for the treatment of obstructive sleep apnea: a qualitative analysis. Sleep Breath 2012;17:659\u201366. https:\/\/doi.org\/10.1007\/s11325-012-0739-6; PMID: 22833346. DOI: 10.1007\/s11325-012-0739-6","DOI":"10.1007\/s11325-012-0739-6"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Gotsopoulos H, Chen C, Qian J, Cistulli PA. Oral appliance therapy improves symptoms in obstructive sleep apnea: a randomized, controlled trial. Am J Respir Crit Care Med 2002;166:743\u20138. https:\/\/doi.org\/10.1164\/rccm.200203-208OC; PMID: 12204875. DOI: 10.1164\/rccm.200203-208OC","DOI":"10.1164\/rccm.200203-208OC"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Bratton DJ, Gaisl T, Wons AM, Kohler M. CPAP vs mandibular advancement devices and blood pressure in patients with obstructive sleep apnea: a systematic review and meta-analysis. JAMA 2015;314:2280\u201393. https:\/\/doi.org\/10.1001\/jama.2015.16303; PMID: 26624827. DOI: 10.1001\/jama.2015.16303","DOI":"10.1001\/jama.2015.16303"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Ramar K, Dort LC, Katz SG, et al. Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy: an update for 2015. J Clin Sleep Med 2015;11:773\u2013827. https:\/\/doi.org\/10.5664\/jcsm.4858; PMID: 26094920. DOI: 10.5664\/jcsm.4858","DOI":"10.5664\/jcsm.4858"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Hoekema A, Voors AA, Wijkstra PJ, et al. Effects of oral appliances and CPAP on the left ventricle and natriuretic peptides. Int J Cardiol 2008;128:232\u20139. https:\/\/doi.org\/10.1016\/j.ijcard.2007.06.016; PMID: 17727981. DOI: 10.1016\/j.ijcard.2007.06.016","DOI":"10.1016\/j.ijcard.2007.06.016"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Kezirian EJ, Goding GS, Jr., Malhotra A, et al. Hypoglossal nerve stimulation improves obstructive sleep apnea: 12-month outcomes. J Sleep Res 2014;23:77\u201383. https:\/\/doi.org\/10.1111\/jsr.12079; PMID: 24033656. DOI: 10.1111\/jsr.12079","DOI":"10.1111\/jsr.12079"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Kezirian EJ, Malhotra A, Goldberg AN, White DP. Changes in obstructive sleep apnea severity, biomarkers, and quality of life after multilevel surgery. Laryngoscope 2010;120:1481\u20138. https:\/\/doi.org\/10.1002\/lary.20946; PMID: 20564750. DOI: 10.1002\/lary.20946","DOI":"10.1002\/lary.20946"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Weaver EM, Maynard C, Yueh B. Survival of veterans with sleep apnea: continuous positive airway pressure versus surgery. Otolaryngol Head Neck Surg 2004;130:659\u201365. https:\/\/doi.org\/10.1016\/j.otohns.2003.12.012; PMID: 15195049. DOI: 10.1016\/j.otohns.2003.12.012","DOI":"10.1016\/j.otohns.2003.12.012"},{"key":"ref37","unstructured":"Bhattacharjee R, Kheirandish-Gozal L, Spruyt K, et al. Adenotonsillectomy outcomes in treatment of obstructive sleep apnea in children: a multicenter retrospective study. Am J Respir Crit Care Med 2010;182:676\u201383. https:\/\/doi.org\/10.1164\/rccm.200912-1930OC; PMID: 20448096."},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Mitchell RB. Adenotonsillectomy for obstructive sleep apnea in children: outcome evaluated by pre- and postoperative polysomnography. Laryngoscope 2007;117:1844\u201354. https:\/\/doi.org\/10.1097\/MLG.0b013e318123ee56; PMID: 17721406. DOI: 10.1097\/MLG.0b013e318123ee56","DOI":"10.1097\/MLG.0b013e318123ee56"},{"key":"ref39","unstructured":"Marcus CL, Moore RH, Rosen CL, et al. A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med 2013;368:2366\u201376. https:\/\/doi.org\/10.1056\/NEJMoa1215881; PMID: 23692173."},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics 1998;102:616\u201320. https:\/\/doi.org\/10.1542\/peds.102.3.616; PMID: 9738185. DOI: 10.1542\/peds.102.3.616","DOI":"10.1542\/peds.102.3.616"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Sher AE. Obstructive sleep apnea syndrome: a complex disorder of the upper airway. Otolaryngol Clin North Am 1990;23:593\u2013608. https:\/\/doi.org\/10.1016\/S0030-6665(20)31240-8; PMID: 2199896. DOI: 10.1016\/S0030-6665(20)31240-8","DOI":"10.1016\/S0030-6665(20)31240-8"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Sher AE. Update on upper airway surgery for obstructive sleep apnea. Curr Opin Pulm Med 1995;1:504\u201311. https:\/\/doi.org\/10.1097\/00063198-199511000-00013; PMID: 9363090. DOI: 10.1097\/00063198-199511000-00013","DOI":"10.1097\/00063198-199511000-00013"},{"key":"ref43","unstructured":"Strollo PJ, Jr., Soose RJ, Maurer JT, et al. Upper-airway stimulation for obstructive sleep apnea. N Engl J Med 2014;370:139\u201349. https:\/\/doi.org\/10.1056\/NEJMoa1308659; PMID: 24401051."},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Malhotra A. Hypoglossal-nerve stimulation for obstructive sleep apnea. N Engl J Med 2014;370:170\u20131. https:\/\/doi.org\/10.1056\/NEJMe1314084; PMID: 24401056. DOI: 10.1056\/NEJMe1314084","DOI":"10.1056\/NEJMe1314084"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Schwartz AR, Barnes M, Hillman D, et al. Acute upper airway responses to hypoglossal nerve stimulation during sleep in obstructive sleep apnea. Am J Respir Crit Care Med 2012;185:420\u20136. https:\/\/doi.org\/10.1164\/rccm.201109-1614OC; PMID: 22135343. DOI: 10.1164\/rccm.201109-1614OC","DOI":"10.1164\/rccm.201109-1614OC"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Schwartz AR, Jacobowitz O, Eisele DW, et al. Targeted hypoglossal nerve stimulation for patients with obstructive sleep apnea: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg 2023;149:512\u201320. https:\/\/doi.org\/10.1001\/jamaoto.2023.0161; PMID: 37022679. DOI: 10.1001\/jamaoto.2023.0161","DOI":"10.1001\/jamaoto.2023.0161"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Jacobowitz O, Schwartz AR, Lovett EG, et al. Design and rationale for the treating Obstructive Sleep Apnea using Targeted Hypoglossal Nerve Stimulation (OSPREY) trial. Contemp Clin Trials 2022;119:106804. https:\/\/doi.org\/10.1016\/j.cct.2022.106804; PMID: 35613672. DOI: 10.1016\/j.cct.2022.106804","DOI":"10.1016\/j.cct.2022.106804"},{"key":"ref48","unstructured":"LivaNova. LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy. 2025. https:\/\/investor.livanova.com\/news-releases\/news-release-details\/livanova-announces-12-month-data-osprey-clinical-study-moderate (accessed 1 June 2025)"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Dixon JB, Schachter LM, O\u2019Brien PE, et al. Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA 2012;308:1142\u20139. https:\/\/doi.org\/10.1001\/2012.jama.11580; PMID: 22990273. DOI: 10.1001\/2012.jama.11580","DOI":"10.1001\/2012.jama.11580"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Malhotra A, Heilmann CR, Banerjee KK, et al. Weight reduction and the impact on apnea-hypopnea index: a systematic meta-analysis. Sleep Med 2024;121:26\u201331. https:\/\/doi.org\/10.1016\/j.sleep.2024.06.014; PMID: 38908268. DOI: 10.1016\/j.sleep.2024.06.014","DOI":"10.1016\/j.sleep.2024.06.014"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Kent D, Stanley J, Aurora RN, et al. Referral of adults with obstructive sleep apnea for surgical consultation: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med 2021;17:2507\u201331. https:\/\/doi.org\/10.5664\/jcsm.9594; PMID: 34351849. DOI: 10.5664\/jcsm.9594","DOI":"10.5664\/jcsm.9594"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Pillar G, Peled R, Lavie P. Recurrence of sleep apnea without concomitant weight increase 7.5 years after weight reduction surgery. Chest 1994;106:1702\u20134. https:\/\/doi.org\/10.1378\/chest.106.6.1702; PMID: 7988187. DOI: 10.1378\/chest.106.6.1702","DOI":"10.1378\/chest.106.6.1702"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Malhotra A, Pettus JH. Continuous positive airway pressure is here to stay. Lancet Respir Med 2024;12:507\u20138. https:\/\/doi.org\/10.1016\/S2213-2600(23)00469-1; PMID: 38768623. DOI: 10.1016\/S2213-2600(23)00469-1","DOI":"10.1016\/S2213-2600(23)00469-1"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Bakker JP, Tavakkoli A, Rueschman M, et al. Gastric banding surgery versus continuous positive airway pressure for obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med 2018;197:1080\u20133. https:\/\/doi.org\/10.1164\/rccm.201708-1637LE; PMID: 29035093. DOI: 10.1164\/rccm.201708-1637LE","DOI":"10.1164\/rccm.201708-1637LE"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the treatment of obstructive sleep apnea and obesity. N Engl J Med 2024;391:1193\u2013205. https:\/\/doi.org\/10.1056\/NEJMoa2404881; PMID: 38912654. DOI: 10.1056\/NEJMoa2404881","DOI":"10.1056\/NEJMoa2404881"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Azarbarzin A, Sands SA, Stone KL, et al. The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the Osteoporotic Fractures in Men Study and the Sleep Heart Health Study. Eur Heart J 2019;40:1149\u201357. https:\/\/doi.org\/10.1093\/eurheartj\/ehy624; PMID: 30376054. DOI: 10.1093\/eurheartj\/ehy624","DOI":"10.1093\/eurheartj\/ehz028"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Packer M, Zile MR, Kramer CM, et al. Tirzepatide for heart failure with preserved ejection fraction and obesity. N Engl J Med 2025;392:427\u201337. https:\/\/doi.org\/10.1056\/NEJMoa2410027; PMID: 39555826. DOI: 10.1056\/NEJMoa2410027","DOI":"10.1056\/NEJMoa2410027"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Hwang JH, Laiteerapong N, Huang ES, Kim DD. Lifetime health effects and cost-effectiveness of tirzepatide and semaglutide in US adults. JAMA Health Forum 2025;6:e245586. https:\/\/doi.org\/10.1001\/jamahealthforum.2024.5586; PMID: 40085108. DOI: 10.1001\/jamahealthforum.2024.5586","DOI":"10.1001\/jamahealthforum.2024.5586"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Javaheri S, Weyne J, Demeester G, Leusen I. Effects of acetazolamide on ionic composition of cisternal fluid during acute respiratory acidosis. J Appl Physiol Respir Environ Exerc Physiol 1984;57:85\u201391. https:\/\/doi.org\/10.1152\/jappl.1984.57.1.85; PMID: 6469795. DOI: 10.1152\/jappl.1984.57.1.85","DOI":"10.1152\/jappl.1984.57.1.85"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Javaheri S, Sands SA, Edwards BA. Acetazolamide attenuates Hunter-Cheyne-Stokes breathing but augments the hypercapnic ventilatory response in patients with heart failure. Ann Am Thorac Soc 2014;11:80\u20136. https:\/\/doi.org\/10.1513\/AnnalsATS.201306-201OC; PMID: 24251826. DOI: 10.1513\/AnnalsATS.201306-201OC","DOI":"10.1513\/AnnalsATS.201306-201OC"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Schmickl CN, Landry SA, Orr JE, et al. Acetazolamide for OSA and central sleep apnea: a comprehensive systematic review and meta-analysis. Chest 2020;158:2632\u201345. https:\/\/doi.org\/10.1016\/j.chest.2020.06.078; PMID: 32768459. DOI: 10.1016\/j.chest.2020.06.078","DOI":"10.1016\/j.chest.2020.06.078"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Schmickl CN, Landry S, Orr JE, et al. Effects of acetazolamide on control of breathing in sleep apnea patients: mechanistic insights using meta-analyses and physiological model simulations. Physiol Rep 2021;9:e15071. https:\/\/doi.org\/10.14814\/phy2.15071; PMID: 34699135. DOI: 10.14814\/phy2.15071","DOI":"10.14814\/phy2.15071"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Schmickl CN, Edwards BA, Malhotra A. Drug therapy for obstructive sleep apnea: are we there yet? Am J Respir Crit Care Med 2022;205:1379\u201381. https:\/\/doi.org\/10.1164\/rccm.202202-0301ED; PMID: 35320066. DOI: 10.1164\/rccm.202202-0301ED","DOI":"10.1164\/rccm.202202-0301ED"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Mullens W, Dauw J, Martens P, et al. Acetazolamide in acute decompensated heart failure with volume overload. N Engl J Med 2022;387:1185\u201395. https:\/\/doi.org\/10.1056\/NEJMoa2203094; PMID: 36027559. DOI: 10.1056\/NEJMoa2203094","DOI":"10.1056\/NEJMoa2203094"},{"key":"ref65","unstructured":"Hudgel DW. Pharmacologic treatment of obstructive sleep apnea. J Lab Clin Med 1995;126:13\u20138. PMID: 7602229."},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Schmickl CN, Orr JE, Alex RM, et al. Combination drug therapy with acetazolamide, eszopiclone \u00b1 venlafaxine for obstructive sleep apnea (RESCUE-combo): a randomized, double-blind, placebo-controlled clinical trial. Ann Am Thorac Soc 2025;22:263\u201373. https:\/\/doi.org\/10.1513\/AnnalsATS.202407-736OC; PMID: 39514000. DOI: 10.1513\/AnnalsATS.202407-736OC","DOI":"10.1513\/AnnalsATS.202407-736OC"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Schmickl CN, Owens RL, Edwards BA, Malhotra A. OSA endotypes: what are they and what are their potential clinical implications? Curr Sleep Med Rep 2018;4:231\u201342. https:\/\/doi.org\/10.1007\/s40675-018-0121-8. DOI: 10.1007\/s40675-018-0121-8","DOI":"10.1007\/s40675-018-0121-8"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Schmickl CN, Owens RL, Orr JE, et al. Side effects of acetazolamide: a systematic review and meta-analysis assessing overall risk and dose dependence. BMJ Open Respir Res 2020;7:e000557. https:\/\/doi.org\/10.1136\/bmjresp-2020-000557; PMID: 32332024. DOI: 10.1136\/bmjresp-2020-000557","DOI":"10.1136\/bmjresp-2020-000557"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Taranto-Montemurro L, Messineo L, Sands SA, et al. The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity. A randomized, placebo-controlled, double-blind crossover trial. Am J Respir Crit Care Med 2019;199:1267\u201376. https:\/\/doi.org\/10.1164\/rccm.201808-1493OC; PMID: 30395486. DOI: 10.1164\/rccm.201808-1493OC","DOI":"10.1164\/rccm.201808-1493OC"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Schweitzer PK, Taranto-Montemurro L, Ojile JM, et al. The combination of aroxybutynin and atomoxetine in the treatment of obstructive sleep apnea (MARIPOSA): a randomized controlled trial. Am J Respir Crit Care Med 2023;208:1316\u201327. https:\/\/doi.org\/10.1164\/rccm.202306-1036OC; PMID: 37812772. DOI: 10.1164\/rccm.202306-1036OC","DOI":"10.1164\/rccm.202306-1036OC"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Sands SA, Collet J, Gell LK, et al. Combination pharmacological therapy targeting multiple mechanisms of sleep apnoea: a randomised controlled cross-over trial. Thorax 2024;79:259\u201368. https:\/\/doi.org\/10.1136\/thorax-2023-220184; PMID: 38286618. DOI: 10.1136\/thorax-2023-220184","DOI":"10.1136\/thorax-2023-220184"},{"key":"ref72","unstructured":"PR Newswire. Apnimed announces positive topline results in the first landmark Phase 3 clinical trial of AD109, an investigational once-daily oral pill for obstructive sleep apnea. 2025. https:\/\/www.prnewswire.com\/news-releases\/apnimed-announces-positive-topline-results-in-the-first-landmark-phase-3-clinical-trial-of-ad109-an-investigational-once-daily-oral-pill-for-obstructive-sleep-apnea-302458517.html (accessed 1 June 2025)"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"McMurray JJV, DeMets DL, Inzucchi SE, et al. A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF). Eur J Heart Fail 2019;21:665\u201375. https:\/\/doi.org\/10.1002\/ejhf.1432; PMID: 30895697. DOI: 10.1002\/ejhf.1432","DOI":"10.1002\/ejhf.1432"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Packer M, Anker SD, Butler J, et al. Effect of empagliflozin on the clinical stability of patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial. Circulation 2021;143:326\u201336. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.051783; PMID: 33081531. DOI: 10.1161\/CIR.0000000000000954","DOI":"10.1161\/CIR.0000000000000954"},{"key":"ref75","unstructured":"Anker SD, Butler J, Filippatos G, et al. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med 2021;385:1451\u201361. https:\/\/doi.org\/10.1056\/NEJMoa2107038; PMID: 34449189."},{"key":"ref76","unstructured":"Solomon SD, McMurray JJV, Claggett B, et al. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med 2022;387:1089\u201398. https:\/\/doi.org\/10.1056\/NEJMoa2206286; PMID: 36027570."},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Wojeck BS, Inzucchi SE, Neeland IJ, et al. Ertugliflozin and incident obstructive sleep apnea: an analysis from the VERTIS CV trial. Sleep Breath 2023;27:669\u201372. https:\/\/doi.org\/10.1007\/s11325-022-02594-2; PMID: 35596030. DOI: 10.1007\/s11325-022-02594-2","DOI":"10.1007\/s11325-022-02594-2"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"Neeland IJ, Eliasson B, Kasai T, et al. The impact of empagliflozin on obstructive sleep apnea and cardiovascular and renal outcomes: an exploratory analysis of the EMPA-REG OUTCOME trial. Diabetes Care 2020;43:3007\u201315. https:\/\/doi.org\/10.2337\/dc20-1096; PMID: 33004464. DOI: 10.2337\/dc20-1096","DOI":"10.2337\/dc20-1096"},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"Kusunoki M, Hisano F, Wakazono N, et al. Effect of treatment with sodium-glucose cotransporter 2 inhibitor on the initiation of continuous positive airway pressure therapy in Type 2 diabetic patients with obstructive sleep apnea syndrome. J Clin Med Res 2021;13:497\u2013501. https:\/\/doi.org\/10.14740\/jocmr4626; PMID: 34925660. DOI: 10.14740\/jocmr4626","DOI":"10.14740\/jocmr4626"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Shetty SS, Krumerman A. Putative protective effects of sodium-glucose cotransporter 2 inhibitors on atrial fibrillation through risk factor modulation and off-target actions: potential mechanisms and future directions. Cardiovasc Diabetol 2022;21:119. https:\/\/doi.org\/10.1186\/s12933-022-01552-2; PMID: 35764968. DOI: 10.1186\/s12933-022-01552-2","DOI":"10.1186\/s12933-022-01552-2"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"Oksenberg A, Silverberg DS, Arons E, Radwan H. Positional vs nonpositional obstructive sleep apnea patients: anthropomorphic, nocturnal polysomnographic, and multiple sleep latency test data. Chest 1997;112:629\u201339. https:\/\/doi.org\/10.1378\/chest.112.3.629; PMID: 9315794. DOI: 10.1378\/chest.112.3.629","DOI":"10.1378\/chest.112.3.629"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Berry RB, Uhles ML, Abaluck BK, et al. NightBalance sleep position treatment device versus auto-adjusting positive airway pressure for treatment of positional obstructive sleep apnea. J Clin Sleep Med 2019;15:947\u201356. https:\/\/doi.org\/10.5664\/jcsm.7868; PMID: 31383231. DOI: 10.5664\/jcsm.7868","DOI":"10.5664\/jcsm.7868"},{"key":"ref83","unstructured":"Oksenberg A, Arons E, Snir D, et al. Cheyne-Stokes respiration during sleep: a possible effect of body position. Med Sci Monit 2002;8:CS61\u20135. PMID: 12118206."},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"Costanzo MR, Ponikowski P, Javaheri S, et al. Transvenous neurostimulation for central sleep apnoea: a randomised controlled trial. Lancet 2016;388:974\u201382. https:\/\/doi.org\/10.1016\/S0140-6736(16)30961-8; PMID: 27598679. DOI: 10.1016\/S0140-6736(16)30961-8","DOI":"10.1016\/S0140-6736(16)30961-8"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Costanzo MR, Ponikowski P, Coats A, et al. Phrenic nerve stimulation to treat patients with central sleep apnoea and heart failure. Eur J Heart Fail 2018;20:1746\u201354. https:\/\/doi.org\/10.1002\/ejhf.1312; PMID: 30303611. DOI: 10.1002\/ejhf.1312","DOI":"10.1002\/ejhf.1312"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Costanzo MR, Javaheri S, Ponikowski P, et al. Transvenous phrenic nerve stimulation for treatment of central sleep apnea: five-year safety and efficacy outcomes. Nat Sci Sleep 2021;13:515\u201326. https:\/\/doi.org\/10.2147\/NSS.S300713; PMID: 33953626. DOI: 10.2147\/NSS.S300713","DOI":"10.2147\/NSS.S300713"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Azarbarzin A, Esmaeili N, Vena D, et al. Determinants of transvenous phrenic nerve stimulation-induced improvements in left ventricular function in central sleep apnea and heart failure. Sleep 2025;48:zsaf085. https:\/\/doi.org\/10.1093\/sleep\/zsaf085; PMID: 40155060. DOI: 10.1093\/sleep\/zsaf085","DOI":"10.1093\/sleep\/zsaf085"},{"key":"ref88","doi-asserted-by":"crossref","unstructured":"Sands SA, Edwards BA, Terrill PI, et al. Identifying obstructive sleep apnoea patients responsive to supplemental oxygen therapy. Eur Respir J 2018;52:1800674. https:\/\/doi.org\/10.1183\/13993003.00674-2018; PMID: 30139771. DOI: 10.1183\/13993003.00674-2018","DOI":"10.1183\/13993003.00674-2018"},{"key":"ref89","doi-asserted-by":"crossref","unstructured":"Mehta V, Vasu TS, Phillips B, Chung F. Obstructive sleep apnea and oxygen therapy: a systematic review of the literature and meta-analysis. J Clin Sleep Med 2013;9:271\u20139. https:\/\/doi.org\/10.5664\/jcsm.2500; PMID: 23493498. DOI: 10.5664\/jcsm.2500","DOI":"10.5664\/jcsm.2500"},{"key":"ref90","doi-asserted-by":"crossref","unstructured":"Gottlieb DJ, Punjabi NM, Mehra R, et al. CPAP versus oxygen in obstructive sleep apnea. N Engl J Med 2014;370:2276\u201385. https:\/\/doi.org\/10.1056\/NEJMoa1306766; PMID: 24918372. DOI: 10.1056\/NEJMoa1306766","DOI":"10.1056\/NEJMoa1306766"},{"key":"ref91","doi-asserted-by":"crossref","unstructured":"Nokes B, Schmickl CN, Brena R, et al. The impact of daytime transoral neuromuscular stimulation on upper airway physiology - a mechanistic clinical investigation. Physiol Rep 2022;10:e15360. https:\/\/doi.org\/10.14814\/phy2.15360; PMID: 35748091. DOI: 10.14814\/phy2.15360","DOI":"10.14814\/phy2.15360"},{"key":"ref92","doi-asserted-by":"crossref","unstructured":"Baptista PM, Mart\u00ednez Ruiz de Apodaca P, Carrasco M, et al. Daytime neuromuscular electrical therapy of tongue muscles in improving snoring in individuals with primary snoring and mild obstructive sleep apnea. J Clin Med 2021;10:1883. https:\/\/doi.org\/10.3390\/jcm10091883; PMID: 33925376. DOI: 10.3390\/jcm10091883","DOI":"10.3390\/jcm10091883"},{"key":"ref93","doi-asserted-by":"crossref","unstructured":"Nokes B, Baptista PM, de Apodaca PMR, et al. Transoral awake state neuromuscular electrical stimulation therapy for mild obstructive sleep apnea. Sleep Breath 2023;27:527\u201334. https:\/\/doi.org\/10.1007\/s11325-022-02644-9; PMID: 35624401. DOI: 10.1007\/s11325-022-02644-9","DOI":"10.1007\/s11325-022-02644-9"},{"key":"ref94","doi-asserted-by":"crossref","unstructured":"Abreu AR, Stefanovski D, Patil SP, et al. Neuromuscular electrical stimulation for obstructive sleep apnoea: comparing adherence to active and sham therapy. ERJ Open Res 2023;9:00474-2023. https:\/\/doi.org\/10.1183\/23120541.00474-2023; PMID: 38152084. DOI: 10.1183\/23120541.00474-2023","DOI":"10.1183\/23120541.00474-2023"}],"container-title":["Cardiac Failure Review"],"original-title":[],"link":[{"URL":"https:\/\/www.cfrjournal.com\/articleindex\/cfr.2025.24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:09:18Z","timestamp":1789063758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cfrjournal.com\/articleindex\/cfr.2025.24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":95,"URL":"https:\/\/doi.org\/10.15420\/cfr.2025.24","relation":{},"ISSN":["2057-7540","2057-7559"],"issn-type":[{"value":"2057-7540","type":"print"},{"value":"2057-7559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"e29"}}